Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

Showing results (91-100 of 284) with videos related to

Pageof 29
Sort By:
Virologica Sinica|April 12, 2013
Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1Zhongyu Zhu, Ponraj Prabakaran, Weizao Chen, et al.
Experimental and Molecular Pathology|July 20, 2002
Differences between CEM and human peripheral blood T lymphocytes in cAMP-dependent HIV viral fusion and CXCR4 expressionAnthony D Cristillo, Xiaodong Xiao, Regina Campbell-Malone, et al.
Translational Oncology|October 3, 2021
Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibodyXianglei Liu, Doncho Zhelev, Cynthia Adams, et al.
Experimental and Molecular Pathology|October 6, 2012
Characterization of human IgG repertoires in an acute HIV-1 infectionWeizao Chen, Ponraj Prabakaran, Zhongyu Zhu, et al.
Journal of Virology|December 13, 2002
Concordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41 binding site in gp120Maria Leavitt, Eun Ju Park, Igor A Sidorov, et al.
Vaccine|December 17, 2008
Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogenMei-Yun Zhang, Yanping Wang, Marie K Mankowski, et al.
Journal of Molecular Biology|January 24, 2006
Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifsPonraj Prabakaran, Jianhua Gan, You-Qiang Wu, et al.
Mabs|December 5, 2019
An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific bindingGuangcan Cao, Xinyu Gao, Yancheng Zhan, et al.
Molecular Pharmaceutics|May 7, 2013
N-terminal truncation of an isolated human IgG1 CH2 domain significantly increases its stability and aggregation resistanceRui Gong, Yanping Wang, Tianlei Ying, et al.
Emerging Microbes & Infections|June 22, 2017
HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virionsQianqian Qi, Qian Wang, Weizao Chen, et al.
Pageof 29

Showing results (91-100 of 284) with videos related to

Sort By:
Pageof 29
Virologica Sinica|April 12, 2013
Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1Zhongyu Zhu, Ponraj Prabakaran, Weizao Chen, et al.
Experimental and Molecular Pathology|July 20, 2002
Differences between CEM and human peripheral blood T lymphocytes in cAMP-dependent HIV viral fusion and CXCR4 expressionAnthony D Cristillo, Xiaodong Xiao, Regina Campbell-Malone, et al.
Translational Oncology|October 3, 2021
Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibodyXianglei Liu, Doncho Zhelev, Cynthia Adams, et al.
Experimental and Molecular Pathology|October 6, 2012
Characterization of human IgG repertoires in an acute HIV-1 infectionWeizao Chen, Ponraj Prabakaran, Zhongyu Zhu, et al.
Journal of Virology|December 13, 2002
Concordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41 binding site in gp120Maria Leavitt, Eun Ju Park, Igor A Sidorov, et al.
Vaccine|December 17, 2008
Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogenMei-Yun Zhang, Yanping Wang, Marie K Mankowski, et al.
Journal of Molecular Biology|January 24, 2006
Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifsPonraj Prabakaran, Jianhua Gan, You-Qiang Wu, et al.
Mabs|December 5, 2019
An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific bindingGuangcan Cao, Xinyu Gao, Yancheng Zhan, et al.
Molecular Pharmaceutics|May 7, 2013
N-terminal truncation of an isolated human IgG1 CH2 domain significantly increases its stability and aggregation resistanceRui Gong, Yanping Wang, Tianlei Ying, et al.
Emerging Microbes & Infections|June 22, 2017
HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virionsQianqian Qi, Qian Wang, Weizao Chen, et al.
Pageof 29